StockData
NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30

NATURAL ALTERNATIVES INTERNATIONAL INC

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.15+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$6.98M
P/E (TTM)
–
Dividend yield
–

NATURAL ALTERNATIVES INTERNATIONAL INC revenue by segment

By business segment

RevenueFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Private Label Contract Manufacturing [Member]$134.62M$121.78M$105.36M$145.29M$154.80M$164.31M$106.29M$121.60M$110.99M$95.02M94.5%+10.5%
Patent and Trademark Licensing [Member]$7.90M$8.08M$8.44M$8.72M$16.17M$14.21M$12.59M$16.69M$21.45M$26.92M5.5%-2.2%
Operating incomeFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017YoY
Patent and Trademark Licensing [Member]$2.69M$3.41M$3.32M$3.02M$6.78M$4.44M$2.51M$2.89M$5.73M$7.53M-21.0%
Private Label Contract Manufacturing [Member]-$12.45M-$1.73M-$3.47M$9.49M$15.67M$17.74M$4.03M$11.23M$8.57M$8.57M+621.0%

By product or service

By region

RevenueFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
United States$93.32M$79.13M$73.51M$109.28M$115.26M$94.70M$66.91M$67.00M$65.48M$63.10M65.5%+17.9%
Non-US [Member]$49.19M$50.73M$40.28M$44.74M$55.71M$83.82M$51.96M$71.29M$66.96M$58.84M34.5%-3.0%

From the segment and revenue-disaggregation notes of Natural Alternatives International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.